FDA Calls for More Restrictions on Fluoroquinolone Use

New Post Public Reply Private Reply Replies (0) Message Board
incubus incubus #25836
FDA Calls for More Restrictions on Fluoroquinolone Use (comments)
By Kristin J. Kelley

Edited by Susan Sadoughi, MD, and André Sofair, MD, MPH

The risks for "disabling and potentially permanent" side effects associated with systemic fluoroquinolone antibacterials (e.g., ciprofloxacin, moxifloxacin) generally outweigh the benefits in patients with sinusitis, bronchitis, and uncomplicated urinary tract infections, the FDA warned late last week. Fluoroquinolones should only be used for these indications when patients don't have other treatment options, the agency said.

Side effects can compromise the nerves, central nervous system, tendons, muscles, and joints. Symptoms may include confusion; hallucinations; joint, muscle, and tendon pain; or a tingling sensation (i.e., "pins and needles".

The action follows advisory panel recommendations made in late 2015 for stronger label warnings. The labels were previously updated in 2013 to warn of increased risk for peripheral neuropathy. Additionally, in 2008, a boxed warning was added to note risks for tendinitis and tendon rupture.

See the linked FDA drug safety communication for a full list of fluoroquinolones currently approved for systemic use.


Link(s):

FDA MedWatch safety alert (Free)

FDA drug safety communication (Free)

FDA briefing document on benefits and risks of systemic fluoroquinolones (Free PDF)

Background: Physician's First Watch coverage of 2015 advisory panel vote (Free)

Reader Comments (11)

Reply
Russell N. Other, Other, Retired
27 May 2016 2:19 PM

I am a victim of Levofloxacin, 4 Achilles tendon tears, Have tried to find Attorney for that, but that ship sailed. However did retain one recently for an aortic aneurysm I suffered about 8 months later. I was blessed it was found on a CT scan for back issues (I have Rheumatoid Disease) If you anyone you know has had issues there is a Facebook page "Fluoroquinolone toxicity Group" Good place for support and references.

Reply
Mark A Girard Other, Disabled by fluoroquinolones!
27 May 2016 4:09 AM

Thanks for reporting on the FDAs much needed warnings that fluoroquinolones, or FQs, should only be used when other options have run out. These drugs are not nearly as safe as once believed. The short list of damage that fluoroquinolones (FQs) did to me includes blood clots, broken blood vessels, bloated failing veins carved from 13 entry points, erratic blood pressure, hemochromatosis, liver damage, kidney damage, pulmonary edema, collapsed lung, hernia, torn lumbar muscle, half dozen bulging discs when I had none a few years before, shrinking eyeballs, tinnitus, multi-chemical sensitivity, gastrointestinal distress, hair loss, crumbling teeth, nosebleeds, nails fall off, spontaneous tendon ruptures, a cartilage transplant, ligament damage, cognitive impairment and other indescribably horrific mental anguish and psychosis, anxiety attacks that had me cowering in a corner, from nothing, and one of the worst, was wicked altitude sickness which forced me to bail abruptly from the town I loved so much, Leadville, Colorado, and now I can't even come to the lower parts of the state without becoming terribly sick. There were/are about a hundred or so other "symptoms" of my fluoroquinolone toxicity, but that gives a quick snapshot of what the last 8.5 yrs have been all about. I cannot tell you how important it is for everyone to learn what the names of these drugs are and to make sure you do not take them, unless you are exposed to anthrax or the plague, and I would actually try my luck with the plague, seriously. I really wish they would have done something less drastic than giving me Levaquin, like cutting off my leg. That is how awful being "floxed" really is. Amputation is less drastic than Levaquin.

Reply
Tracy Jean Other, disabled
19 May 2016 12:28 AM

Thank you FDA .This is overdue. Cipro disabled me 2 years ago. I was unable to work in my profession as a social worker. I had no idea an antibiotic could wreck my body, my career, my social life, and my family counting on me. Wayyyyyy overdue. Wake up.

Reply
Debbie
18 May 2016 1:36 PM

Call your health Insurance requesting that they turn down prescriptions for Floxin medicines for urinary tract and sinus infections as the FDA says doctors need not to prescribe for this ! Tell them they will save money afterwards with all the damage the cause ! Maybe the message will get out to doctors and hospitals to rid or at least slow down these meds . I hope to at least make the doctors comply with these findings ! Let us do our part in getting the word out to our Health insurance they have to clean up what the FDA refuses to see that this medicine needs to be pulled !!

Reply
Cassie Other, Other
18 May 2016 12:17 PM

In 2012 I was prescribed Cipro. No way would I have ever believed the outcome and especially that the one stupid pill I took could hurt me so bad. If someone else had told me that, I'd have probably been like some of the other people I've met, in disbelief. It's impossible to fathem the amount of pain it put me in or describe my pain in details that could be felt, but it was so bad that I had to have an MRI on my knee the following day, which cost us over $400 after insurance. Doctors have told me repeatedly it wasn't the Cipro, but unfortunately their simply saying that can't change the facts to fit their response. I was there! I have kept all of my records. I'm not a hypochondriac and rarely see the doctor more than once a year for my annual thyroid test. I was physically fit and in perfect health, minus a stomach pain that wound up being diagnosed as IBS, taking Cipro "just in case" it might be diverticulitis at 34. It was a very huge mistake on my part, that has caused me to fear all prescription drugs. I still have joint, muscle and tendon pain four years later that can't be cured. It moves around and comes in flares. Sometimes remitting for a while, only to come back. I'm not sure it'll ever go away permanently, but I continue to work and am doing way better than most. Thank you for your coverage on the FDA's new warnings. I'm glad others might be saved going through the same.

Reply
Rose Schmidt, M.S., P.G. Other, Other
18 May 2016 12:52 AM

Thank you for covering this story within the medical community. Like others, I was first met with denial and disbelief when I went to my PCP describing my 'flox' symptoms. I brought her journal articles, etc., detailing how fluoroquinolones damage collagen. She was kind, caring, and compassionate. After she read the material, I could tell that she was shocked and saddened, that this commonly prescribed antibiotic could inflict so much harm, when she had dedicated her career to patient care. Even once she acknowledged the FQs as the cause, she still felt helpless, because she didn't know what to do for me, as there is no established treatment protocol to reverse the damage. The FDA has finally acknowledged the damage FQs cause, which is a step in the right direction.

Reply
Donna Sumner Other, Other, St George, Utah
17 May 2016 2:35 AM

Has there been any myelitis as a result of the cipro

Reply
Mandy
16 May 2016 9:35 PM

Thank you for covering this important and potentially life saving story! I have been suffering from levaquin poisoning since 2006. More than 9 years after taking my final fluoroquinolone pill, I still can not function as well as many 80 year olds. I am 48 and I have a good friend who is 84 and she has had to help me carry groceries because her back and joints are healthier than mine. I was very athletic the until the day I got postnasal drip and took levaquin. Doctors are NOT aware of how dangerous these drugs are. In fact, when I have gone to doctors for help to find treatment for the levaquin side effects, many of those doctors have literally laughed at me and they insisted that levaquin is extremely safe and couldn't possibly cause any long term side effects. SOMEONE has worked hard to convince doctors that these drugs are as safe a candy. Something MUST be done to correct that very dangerous and very wrong perception among so many doctors. They need to know that these antibiotics can completely disable (and even kill) a young, healthy and athletic person. They are far from safe drugs and this has been known for many years. Just look at the peer reviewed studies on mitochondrial toxicity from fluoroquinolones. Thank you for helping to spread awareness.

Reply
Simo Other
16 May 2016 6:28 PM

This announcement by the FDA is a huge step in the right direction. These fluoroquinolone antibiotics can ruin your life. Cipro changed me from a very athletic and active person to one that averages a major tendon/joint surgery every 2 years. Seven surgeries in 13 years with more needed all thanks to the permanent damage this antibiotic did to my tendons. The FDA is now admitting how dangerous these drugs are and hopefully doctors take heed and don't dismiss these severe adverse reactions as rare because they aren't. Bravo FDA, now please educate the medical industry so that our kids and their kids can avoid this nightmare.

Reply
Berry, BA Other, Other
16 May 2016 4:53 PM

Disabled since 2001 after taking 5 Cipro tablets

Reply
Elizabeth Lo Geriatrics
16 May 2016 4:44 PM

Long overdue! Too many have been permanently and severely injured by these chemotherapeutic drugs disguised as antibiotics. Hopefully, these drugs will now only be prescribed in life threatening situations after all other options have been exhausted.

Innovation Pharmaceuticals Inc (IPIX) Stock Research Links

IPIX Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

VIZ Media Expands Reach with MangaPlaza Partnership

Updated Category News Views 23

Manga Magic in the Digital Space Another day, another expansion, folks. VIZ Media's latest move to have its manga offerings available on MangaPlaza feels like a pretty shrewd play in the fierce arena of digital content. Who'd have thought decades ago that we'd be sitting here talking about digital comics like they’re the next Netflix? VIZ Media's expansion into...

Continue Reading
BellRing Brands Lawsuit Hinges on Sales Misrepresentation

Updated Category News Views 66

BellRing's Legal Tangle Deepens When it comes to drawing the line between having a good quarter and pulling the wool over investors' eyes, the latest lawsuit knotted up with BellRing Brands, Inc. (NYSE: BRBR) shows just how fine that line can be. This legal drama, filed on the not-so-distant date of January 22, 2026, isn't your garden-variety beef. We're talking...

Continue Reading
Keith Strachan Elevates The Master Group's Strategy

Updated Category News Views 38

Strachan Steps Up as Chief Commercial Officer Keith Strachan is stepping into the role of Chief Commercial Officer at The Master Group—big news up in St-Bruno-de-Montarville. Now, those not neck-deep in HVAC-R might shrug this one off, but for those eyeing the industry, this is where the cards start to shuffle in North America. Master’s shift isn't just paper-pushing;...

Continue Reading
MPLX Adds Industry Veterans to Board Leadership

Updated Category News Views 104

A New Era for MPLX's Board Nothing shakes up the scene like announcing two heavyweights joining the board, and that's exactly what MPLX LP (NYSE: MPLX) just pulled off. Micheal G. Dunn and Bruce L. Niemeyer are coming onboard, effective November 1, 2026. With pedigrees that could make any industry insider nod in approval, these guys bring decades of experience to the...

Continue Reading
Webull Faces Class Action: Investor Impact Deep Dive

Updated Category News Views 24

What's Going On with Webull? Ah, Webull Corporation, you're in the hot seat now. If you blinked on October 7th, you might have missed a monumental 19.09% cliff dive in Webull's stock, tumbling down to a humble $5.89. The roar wasn't just the market reacting; it was the sonic boom of a class action lawsuit on their heels, alleging some slick legal sledding with misleading...

Continue Reading
Wood Partners Expands Charlotte Footprint with New Project

Updated Category News Views 22

Charlotte's Expansion Beckons New Development at Village Park Charlotte's skyline is about to get a new neighbor in a growing district, as Wood Partners is set to break ground yet again, unveiling its ambitious plans for Village Park. This is not just a hodgepodge construction talk—it’s the company’s latest effort to plant its flag deep in the heart of the Queen...

Continue Reading
Duolingo Lawsuit Looms Over Securities Allegations

Updated Category News Views 26

Duolingo Lawsuit: A New Headache for Investors Seems like every time you blink, another tech darling is getting dragged to court, and now it's Duolingo's turn to face the music. They're locked in a class action lawsuit food-fight over violations of the Securities Exchange Act of 1934, specifically, §§10(b) and 20(a), and Rule 10b-5. The Core of Allegations Against...

Continue Reading
Young Leaders Drive Be Strong’s Mental Health Movement

Updated Category News Views 62

New Voices at the Helm Today’s youth aren’t just tomorrow's leaders; they’re stepping up now. Groups like Be Strong’s newly minted National Student Advisory Board are proving that. Sixteen kids across eleven states are diving headfirst into transforming mental health narratives. This ain't just some school club. These young guns are gearing up to reshape how we...

Continue Reading
Historic Williamsburg Loft Gets a Modern Makeover

Updated Category News Views 46

Breathing New Life into a Brooklyn Classic Alright, picture this: You're stepping into a century-old Brooklyn loft, expecting dust, aged wood, maybe a ghost or two. What you actually find is art wrapped in brass with a splash of modern flair. This ain't just any loft, folks—it's the latest trophy on the mantle for Gallery KBNY, a design-build firm known for its...

Continue Reading
Cat Financial Shows Solid Q3 Growth Amid Challenges

Updated Category News Views 131

Healthy Gains in Revenues and Profits Well, Cat Financial's latest report is another piece of the puzzle showing steady, if not spectacular, growth. They've jacked up their revenues by 10% for the third quarter of 2026 compared to last year's same stretch. This puts the revenues at $1.02 billion, a $95 million bump from the previous year. Pretty impressive. The profit saw...

Continue Reading

Top 5 Most Recently Viewed Articles

Syntheia Appoints Travel Industry Leader John Kirk to Advisory Board

Updated Category News Views 246

Syntheia Welcomes New Advisory Board Member Syntheia Corp. (“Syntheia” or the “Company”) (CSE – SYAI), a forefront player in conversational AI SaaS, is thrilled to announce the formation of its new Advisory Board. This Board, composed of industry leaders, will work closely with Syntheia's management and board members to bolster the strategic direction of the...

Continue Reading
Investor Sentiment in Euro Zone Declines Significantly

Updated Category News Views 164

Decline in Euro Zone Investor Sentiment Recent surveys reveal that investor morale in the euro zone has reached its lowest point in over a year. This sharp decline reflects ongoing economic challenges, notably the persistent recession in Germany, which casts a shadow over the entire region. Sentix Index Insights The Sentix index, a key measure of investor sentiment in the...

Continue Reading
PRQ Exteriors: Excellence in Roofing and Customer Care

Updated Category News Views 195

Craftsmanship and Compassion in Roofing Services When it comes to roofing, it's not just about shingles and installation; it's about treating each home with respect and care. PRQ Exteriors exemplifies this philosophy through its exceptional services in the Denver area. Bruce Andrews, a homeowner, experienced their commitment firsthand when his roof needed replacement. He...

Continue Reading
Aircastle's Upcoming Fourth Quarter Results Announcement

Updated Category News Views 140

Aircastle Limited Announces Financial Results Schedule Aircastle Limited, a key player in the aviation financing market, is set to release its fourth quarter and full year financial results for the period ending February 28, 2025. The announcement is scheduled for April 23, 2025, prior to the market opening, a moment anticipated by investors and stakeholders alike....

Continue Reading
Castellum Secures $3.2 Million Contract for Cybersecurity Enhancements

Updated Category News Views 190

Castellum Achieves Significant Contract Win Castellum, Inc. (NYSE-American: CTM) has recently announced that its Specialty Systems, Inc. subsidiary has been awarded a substantial contract valued at $3.2 million. This contract spans 18 months and focuses on enhancing the Cyber-Supply Chain Risk Management (C-SCRM) capabilities specifically for Aircraft Launch and Recovery...

Continue Reading